Ashland

Celecoxib (CXB) is a Biopharmaceutical Classification System (BCS) Class II molecule with high permeability that is practically insoluble in water....

The nasal physiology offers great potential for drug delivery but also poses specific challenges, among which the short residence time...

advancing drug delivery Ashland’s pharmaceutical team prides itself on advancing drug delivery with sophisticated science-based solutions. Our global centers of...

Particle size reduction is a commonly used process to improve the solubility and the dissolution of drug formulations. The solubility...

The model of core–shell structured tablets is gaining increased interest due to its advantages in controlled-release and combinational drug delivery....

This paper aims to give an overview of our current research and development on hot-melt extrusion (HME) for pharmaceutical formulation...

Bilayer/multilayer tablets have been introduced to formulate incompatible components for compound preparations, but they are now more commonly used to...

Coupling hot-melt extrusion (HME) with fused deposition modeling three-dimensional printing (FDM-3DP) can facilitate the fabrication of tailored, patient-centered, and complex-shaped...

This work gives a brief overview of carrier materials currently used in pharmaceutical studies on the three-dimensional (3D) semi-solid extrusion...

Bacterial vaginosis (BV) is an abnormal condition caused by the change of microbiota in the vagina. One of the most...